 |
|---|
CardioComm Solutions Inc. Announces Licensing Agreement with World Renowned Customer
|
VICTORIA, B.C., May 11, 2004 – CardioComm Solutions Inc. (TSX-V:CCG) (the "Company", "CardioComm"), is pleased to announce that it has signed a Software License and Support Agreement with the Mayo Foundation (“Mayo”).
This agreement is for the license of CardioComm’s ECG Control Software Developers Kit (“SDK”). Mayo will embed CardioComm’s ECG SDK into an upgraded version of its internally developed database, reporting system and workflow for trans-telephonic pacemaker follow-ups. This fully electronic system will replace the Mayo’s existing trans-telephonic pacemaker follow-up receiving stations.
Stephen Martin, CardioComm’s CEO commented, “In June 2001, Mayo Foundation licensed our popular arrhythmia follow-up software called GEMS™ for use in their Rochester clinic. Today’s announcement marks the second contract we have signed with them. Naturally, we are very pleased that Mayo has opted to integrate our software developers kit as part of their trans-telephonic pacemaker follow-up systems”.
About CardioComm Solutions Inc: CardioComm's patented and proprietary technology is used in products for the recording, viewing, analyzing and storing of electrocardiograms (ECGs), for diagnosis and management of cardiac patients. CardioComm has achieved its technical goals of improved access and communication through the development of a real-time ECG viewer. CardioComm is the first company to provide a real-time means of viewing ECGs over a network (LAN, WAN or Internet). This tool enables ECGs to be viewed and controlled live, by physicians, over a global virtual healthcare network. This technology is marketed as Global ECG Management System (GEMS™) and GlobalCardio™. CardioComm's software products have been cleared for sale in the United States by the U.S. Food and Drug Administration. The Company has earned the latest ISO 13485 certification.
|
On behalf of the Board of Directors of CardioComm Solutions Inc.:
“Stephen Martin”
Stephen R. Martin, President & CEO
For investor information, please contact: Stephen Martin |
